Loading...
0

Cardiac Ablation Devices Market by Product (Radiofrequency Ablators, Electrical Ablators, Cryoablation Devices, Ultrasound Ablators, and Microwave Ablators), Technology (Radiofrequency Ablation, Electrical Ablation, Cryoablation, Ultrasound Ablation, Microwave Ablation, and Others), Function (Automated and Conventional), and Application (Cardiac Rhythm Management and Open Surgery): Global Opportunity Analysis and Industry Forecast, 2019–2026

LI_184840
Pages: NA
Nov 2019 | 323 Views
 
Author(s) : NA
Tables: NA
Charts: NA
 

Cardiac ablation is a medical procedure that can correct cardiac arrythmias through scarring small areas in the heart. Cardiac arrythmias occur when the electrical signals that control the heartbeats are misfunctioning. As a result, the heartbeats become abnormal and if left untreated, may lead to stroke or heart failure and is one of the leading causes of death. There are various factors that can be associated with the cardiac arrythmia. These include pre-existing medical conditions such as diabetes, hypertension, hyperthyroidism, mental stress, heart conditions, old age, and other such factors as well as lifestyle associated factors such as smoking, alcohol abuse, drug abuse, excessive caffeine consumption, and others. Furthermore, consumption of some dietary supplements, herbal treatments, and some medicine may also lead to cardiac arrythmia. Thus, one of the successful treatments that follows to treat such conditions includes cardiac ablation. The cardiac ablation procedure being minimally invasive, is less painful than conventional surgical operations, and leads to shorter recovery time. Over the last decade, cardiac ablation devices have undergone various technical advancements, thereby aiming for better ablation outcomes and reliability.

The global cardiac ablation devices market is anticipated to register substantial growth, attributed to the rise in geriatric population and increase in population base of cardiovascular diseases. In addition, various technological advancements in ablation devices and arrythmia diagnostic devices further drive the growth of the market. However, risk of complications associated with the procedure such as damage to blood vessels, damage to heart valves, infection, venous thromboembolism, and other such complications restrain the growth of the market. Furthermore, rise in prevalence of hospital-acquired infections associated with catheters further restrict the market growth. In contrast, introduction of advanced robotic technologies in cardiac ablation makes the process safer and more accurate, offering high growth opportunities to key players. In addition, the growing market penetration of ablation product manufacturers across developing countries also offers high growth opportunities for the global cardiac ablation device market.

The cardiac ablation devices market is segmented on the basis of product, technology, function, application, and region. Based on product, the market is segmented as radiofrequency ablators, electrical ablators, cryoablation devices, ultrasound ablators, and microwave ablators. Based on technology, the market is bifurcated into radiofrequency ablation, electrical ablation, cryoablation, ultrasound ablation, microwave ablation, and others. Based on function, the market is segmented as automated and conventional. Depending on the application, the market is classified into cardiac rhythm management, open surgery, and others. Cardiac rhythm management is further sub-segmented into cardiac arrhythmia, atrial fibrillation & flutter, tachycardia. Region wise, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.

The report provides a comprehensive analysis of the key players operating in global cardiac ablation devices market such as Abbott Laboratories, Alcon Laboratories Inc., Stryker Corporation, Olympus Corporation, MicroPort Inc., Boston Scientific Corporation, CardioFocus Inc., Johnson & Johnson (Biosense Webster, Inc.), Advanced Cardiac Therapeutics, and CONMED Corporation. Other players in the value chain includes Medtronic Plc, AngioDynamics, Inc., Therapeutics, Inc., AtriCure, Inc., Toray Industries, Inc., and others.

KEY BENEFITS FOR STAKEHOLDERS:

  • An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
  • A comprehensive analysis of the factors that drive and restrain the growth of the global cardiac ablation devices market is provided.
  • Region-wise and country-wise cardiac ablation devices market conditions are comprehensively analyzed in this report.
  • The projections in this report are made by analyzing the current market trends and future market potential from 2019 to 2026 in terms of value.
  • An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
  • Key market players within the cardiac ablation devices market are profiled in this report, and their strategies are analyzed thoroughly, which helps to understand the competitive outlook of global Cardiac Ablation Device Market.

KEY MARKET SEGMENTS:

By Product

  • Radiofrequency (RF) Ablators
    • Temperature-controlled Radiofrequency Ablators
    • Fluid-cooled Radiofrequency Ablators
    • Robotic Catheter Manipulation Systems
  • Electrical Ablators
    • Argon Plasma/Beam Coagulators
    • Irreversible Electroporation Systems
  • Cryoablation Devices
    • Tissue Contact Probes
    • Tissue Spray Probes
  • Ultrasound Ablators
    • High-intensity Focused Ultrasound Ablators
    • Magnetic Resonance Guided Focused Ultrasound Ablators
    • Ultrasound Ablation Systems
  • Microwave Ablators
    • Microwave Thermotherapy Devices

By Technology

  • Radiofrequency (RF) Ablation
  • Electrical Ablation
  • Cryoablation
  • Ultrasound Ablation
  • Microwave Ablation
  • Others

By Function

  • Automated
  • Conventional

By Application

  • Cardiac Rhythm Management
  • Cardiac Arrhythmia
  • Atrial Fibrillation and Flutter
  • Tachycardia
  • Open Surgery

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • Australia
    • Japan
    • India
    • China
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. GLOBAL TOP PLAYER POSITIONING, 2017
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. MARKET ENTERING STRATEGY
3.6. PEST ANALYSIS
3.6.1. Brazil
3.6.2. China
3.6.3. France
3.6.4. The Netherlands
3.6.5. India
3.6.6. Japan
3.6.7. Canada
3.6.8. South Korea
3.6.9. Germany
3.6.10. Switzerland
3.7. KEY MARKET TRENDS AND GROWTH FACTORS
3.7.1. Brazil
3.7.2. China
3.7.3. France
3.7.4. The Netherlands
3.7.5. India
3.7.6. Japan
3.7.7. Canada
3.7.8. South Korea
3.7.9. Germany
3.7.10. Switzerland
3.8. TOP PLAYER POSITIONING, 2017
3.8.1. Brazil
3.8.2. China
3.8.3. France
3.8.4. The Netherlands
3.8.5. India
3.8.6. Japan
3.8.7. Canada
3.8.8. South Korea
3.8.9. Germany
3.8.10. Switzerland

CHAPTER 4 CARDIAC ABLATION DEVICES MARKET, BY PRODUCT

4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. RADIOFREQUENCY ABLATION
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. CRYOABLATION
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. LASER ABLATION
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. OTHERS
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country

CHAPTER 5 CARDIAC ABLATION DEVICES MARKET, BY FUNCTION

5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. AUTOMATED/ROBOTIC
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. CONVENTIONAL
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country

CHAPTER 6 CARDIAC ABLATION DEVICES MARKET, BY APPLICATION

6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. ATRIAL FIBRILLATION
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. TACHYCARDIA
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
6.4. CORONARY ARTERY OR VALVE DISEASE
6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country
6.5. OTHERS
6.5.1. Market size and forecast, by region
6.5.2. Market analysis, by country

CHAPTER 7 CARDIAC ABLATION DEVICES MARKET, BY REGION

7.1. OVERVIEW
7.2. NORTH AMERICA
7.2.1. Key market trends, growth factors and opportunities
7.2.2. North America cardiac ablation devices market, by country
7.2.2.1. U.S. cardiac ablation devices market
7.2.2.1.1. U.S. market, by product
7.2.2.1.2. U.S. market, by function
7.2.2.1.3. U.S. market, by application
7.2.2.2. Canada cardiac ablation devices market
7.2.2.2.1. Canada market, by product
7.2.2.2.2. Canada market, by function
7.2.2.2.3. Canada market, by application
7.2.2.3. Mexico cardiac ablation devices market
7.2.2.3.1. Mexico market, by product
7.2.2.3.2. Mexico market, by function
7.2.2.3.3. Mexico market, by application
7.2.3. North America cardiac ablation devices market, by product
7.2.4. North America cardiac ablation devices market, by function
7.2.5. North America cardiac ablation devices market, by application
7.3. EUROPE
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Europe cardiac ablation devices market, by country
7.3.2.1. Germany cardiac ablation devices market
7.3.2.1.1. Germany market, by product
7.3.2.1.2. Germany market, by function
7.3.2.1.3. Germany market, by application
7.3.2.2. France cardiac ablation devices market
7.3.2.2.1. France market, by product
7.3.2.2.2. France market, by function
7.3.2.2.3. France market, by application
7.3.2.3. UK cardiac ablation devices market
7.3.2.3.1. UK market, by product
7.3.2.3.2. UK market, by function
7.3.2.3.3. UK market, by application
7.3.2.4. Italy cardiac ablation devices market
7.3.2.4.1. Italy market, by product
7.3.2.4.2. Italy market, by function
7.3.2.4.3. Italy market, by application
7.3.2.5. Spain cardiac ablation devices market
7.3.2.5.1. Spain market, by product
7.3.2.5.2. Spain market, by function
7.3.2.5.3. Spain market, by application
7.3.2.6. Switzerland cardiac ablation devices market
7.3.2.6.1. Switzerland market, by product
7.3.2.6.2. Switzerland market, by function
7.3.2.6.3. Switzerland market, by application
7.3.2.7. The Netherlands cardiac ablation devices market
7.3.2.7.1. The Netherlands market, by product
7.3.2.7.2. The Netherlands market, by function
7.3.2.7.3. The Netherlands market, by application
7.3.2.8. Rest of Europe cardiac ablation devices market
7.3.2.8.1. Rest of Europe market, by product
7.3.2.8.2. Rest of Europe market, by function
7.3.2.8.3. Rest of Europe market, by application
7.3.3. Europe cardiac ablation devices market, by product
7.3.4. Europe cardiac ablation devices market, by function
7.3.5. Europe cardiac ablation devices market, by application
7.4. ASIA-PACIFIC
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Asia-Pacific cardiac ablation devices market, by country
7.4.2.1. Japan cardiac ablation devices market
7.4.2.1.1. Japan market, by product
7.4.2.1.2. Japan market, by function
7.4.2.1.3. Japan market, by application
7.4.2.2. China cardiac ablation devices market
7.4.2.2.1. China market, by product
7.4.2.2.2. China market, by function
7.4.2.2.3. China market, by application
7.4.2.3. Australia cardiac ablation devices market
7.4.2.3.1. Australia market, by product
7.4.2.3.2. Australia market, by function
7.4.2.3.3. Australia market, by application
7.4.2.4. India cardiac ablation devices market
7.4.2.4.1. India market, by product
7.4.2.4.2. India market, by function
7.4.2.4.3. India market, by application
7.4.2.5. South Korea cardiac ablation devices market
7.4.2.5.1. South Korea market, by product
7.4.2.5.2. South Korea market, by function
7.4.2.5.3. South Korea market, by application
7.4.2.6. Rest of Asia-Pacific cardiac ablation devices market
7.4.2.6.1. Rest of Asia-Pacific market, by product
7.4.2.6.2. Rest of Asia-Pacific market, by function
7.4.2.6.3. Rest of Asia-Pacific market, by application
7.4.3. Asia-Pacific cardiac ablation devices market, by product
7.4.4. Asia-Pacific cardiac ablation devices market, by function
7.4.5. Asia-Pacific cardiac ablation devices market, by application
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. LAMEA cardiac ablation devices market, by country
7.5.2.1. Brazil cardiac ablation devices market
7.5.2.1.1. Brazil market, by product
7.5.2.1.2. Brazil market, by function
7.5.2.1.3. Brazil market, by application
7.5.2.2. Saudi Arabia cardiac ablation devices market
7.5.2.2.1. Saudi Arabia market, by product
7.5.2.2.2. Saudi Arabia market, by function
7.5.2.2.3. Saudi Arabia market, by application
7.5.2.3. South Africa cardiac ablation devices market
7.5.2.3.1. South Africa market, by product
7.5.2.3.2. South Africa market, by function
7.5.2.3.3. South Africa market, by application
7.5.2.4. Rest of LAMEA cardiac ablation devices market
7.5.2.4.1. Rest of LAMEA market, by product
7.5.2.4.2. Rest of LAMEA market, by function
7.5.2.4.3. Rest of LAMEA market, by application
7.5.3. LAMEA cardiac ablation devices market, by product
7.5.4. LAMEA cardiac ablation devices market, by function
7.5.5. LAMEA cardiac ablation devices market, by application

CHAPTER 8 COMPANY PROFILES

8.1. ABBOTT LABORATORIES
8.1.1. Operating business segments
8.1.2. Business performance
8.1.3. Key strategic moves and developments
8.1.4. SWOT analysis
8.2. ADVANCED CARDIAC THERAPEUTICS, INC.
8.2.1. Operating business segments
8.2.2. Business performance
8.2.3. Key strategic moves and developments
8.2.4. SWOT analysis
8.3. ANGIODYNAMICS, INC.
8.3.1. Operating business segments
8.3.2. Business performance
8.3.3. Key strategic moves and developments
8.3.4. SWOT analysis
8.4. ATRICURE, INC.
8.4.1. Operating business segments
8.4.2. Business performance
8.4.3. Key strategic moves and developments
8.4.4. SWOT analysis
8.5. BOSTON SCIENTIFIC CORPORATION
8.5.1. Operating business segments
8.5.2. Business performance
8.5.3. Key strategic moves and developments
8.5.4. SWOT analysis
8.6. C.R. BARD, INC.
8.6.1. Operating business segments
8.6.2. Business performance
8.6.3. Key strategic moves and developments
8.6.4. SWOT analysis
8.7. CONMED CORPORATION
8.7.1. Operating business segments
8.7.2. Business performance
8.7.3. Key strategic moves and developments
8.7.4. SWOT analysis
8.8. JOHNSON & JOHNSON
8.8.1. Operating business segments
8.8.2. Business performance
8.8.3. Key strategic moves and developments
8.8.4. SWOT analysis
8.9. MEDTRONIC PLC
8.9.1. Operating business segments
8.9.2. Business performance
8.9.3. Key strategic moves and developments
8.9.4. SWOT analysis
8.10. TERUMO CORPORATION
8.10.1. Operating business segments
8.10.2. Business performance
8.10.3. Key strategic moves and developments
8.10.4. SWOT analysis

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry

REQUEST TOC/SAMPLE

Request Customization

REQUEST TOC/SAMPLE

OR

Purchase Full Report of
Cardiac Ablation Devices Market

  • Online Only
  • $3,456  $3,110
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,370  $4,833
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $5,805
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8,995  $8,096
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 
REQUEST TOC/SAMPLE

Buy Full Version
"Cardiac Ablation Devices Market"
Purchase Enquiry